Rongqiang Liu Selected Research

Hypertension (High Blood Pressure)

1/2022

Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic Cervical Cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongqiang Liu Research Topics

Disease

15	Neoplasms (Cancer) 11/2023 - 02/2008
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 12/2020
2	Breast Neoplasms (Breast Cancer) 07/2023 - 06/2023
2	Inflammation (Inflammations) 01/2023 - 01/2021
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 10/2019
2	Digestive System Neoplasms (Cancer of the Digestive System) 04/2021 - 01/2021
1	Carcinoma (Carcinomatosis) 11/2023
1	Sarcopenia 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023
1	Carcinogenesis 06/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Hepatitis 01/2023
1	Chagas Disease (American Trypanosomiasis) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hypothyroidism 01/2022
1	Cholangiocarcinoma 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Atrial Fibrillation 01/2021
1	Rabies (Hydrophobia) 01/2021
1	Chronic Hepatitis B 01/2021
1	Infections 02/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Heart Arrest (Cardiac Arrest) 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2019
1	Brain Injuries (Brain Injury) 08/2019
1	Hypoxia (Hypoxemia) 12/2018
1	Anemia 12/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2018
1	Reperfusion Injury 07/2018
1	Myocardial Infarction 07/2018
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2008

Drug/Important Bio-Agent (IBA)

6	Indicators and Reagents (Reagents)IBA 11/2023 - 10/2019
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2019
4	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 07/2023 - 01/2022
3	vasectrin I (VS I)IBA 01/2023 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 01/2020
2	AlbuminsIBA 01/2022 - 01/2022
2	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2021
1	imidazoleacetic acid (IMAC)IBA 11/2023
1	Circular RNAIBA 06/2023
1	threonic acid (threonate)IBA 01/2023
1	Alanine (L-Alanine)FDA Link 01/2023
1	CholatesIBA 01/2023
1	stachydrineIBA 01/2023
1	sintilimabIBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	BilirubinIBA 01/2022
1	SphingolipidsIBA 01/2022
1	anlotinibIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Aldo-Keto Reductase Family 1 member B10IBA 04/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Aldo-Keto ReductasesIBA 01/2021
1	AnticoagulantsIBA 01/2021
1	Aurora Kinase AIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2021
1	Proton Pump InhibitorsIBA 12/2020
1	VaccinesIBA 02/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Uncoupling Protein 2IBA 08/2019
1	GhrelinIBA 08/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2018
1	FlavonoidsIBA 07/2018
1	IsoenzymesIBA 07/2018
1	baicaleinIBA 07/2018

Therapy/Procedure

4	Hepatectomy 11/2023 - 01/2020
2	Therapeutics 01/2022 - 01/2021
1	Immunotherapy 01/2022
1	Precision Medicine 01/2021
1	Cardiopulmonary Resuscitation (CPR) 08/2019
1	Resuscitation 08/2019
1	Radiotherapy 02/2008